Nowadays, more and more advanced and innovative technologies are moving from laboratory to clinical application, and the direction represented by innovative immunotherapy is facing unprecedented opportunities, which opens up a brand-new way of thinking for the treatment of intractable human diseases and will have a revolutionary impact on human health.
To grasp the new trend of accelerated iteration of global advanced technology, it is necessary to gather basic, clinical, industrial, regulatory and other synergistic linkage, cooperation and research, including from the prospective layout of the original innovation, clinical translation and application, industry upstream and downstream synergy, regulatory assistance, policy support and so on.
The Institute actively expands the flexible cooperation mode with cutting-edge innovative enterprises, supports the research and development, clinical translation, and industrial application of advanced innovative technologies and drugs, and provides the whole chain of technical services to accelerate the R&D and marketing of products and successful transformation, thus promoting the high-quality development of scientific and technological innovation and industry.
| Technical Service Contents | Detailed content |
| Pharmacological Evaluation | CMC Development Strategy |
| IIT studies | Clinical site screening, clinical indication selection, study protocols, study tracking, biospecimen analysis |
| Registration | IND/NDA registration filing strategy, regulatory counselling, change strategy |
| Compliance Evaluation | GMP compliance evaluation, research and development compliance, post-market changes |
Contact: Dr. Wang
Email: sitipartner@163.com
Tel：021-68382517
Zip code: 200127
上海市免疫治疗创新研究院 版权所有 备案号：沪ICP备09022836号 公安备案号：31011502003436 访问量：
